March 11 (Reuters) - India's Zydus Lifesciences (ZYDU.NS), opens new tab said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA), opens new tab for 256.8 million ...

Zydus Lifesciences has entered exclusive negotiations to acquire a controlling stake in France-based medtech firm Amplitude Surgical SA for €256.8 million, the drugmaker said on Tuesday, as it ...

The proposed acquisition shall act as a platform to execute our global MedTech strategy and a natural extension for Zydus having a proven track record in life sciences and wellness segments ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

Homegrown pharma company Zydus Lifesciences Ltd announced on Tuesday its strategic move into the medical technology sector through the acquisition of a controlling stake in French orthopaedics firm ...

(Image Credits: Pixabay) Zydus on Wednesday said that a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients.